Formulated to support synthetic operations, this Spe Polypropylene Column Chromabond® Drug is designed for drug analysis in a specialized silica gel phase. With a bifunctional modification of C8/SA (strong cation exchanger – benzenesulfonic acid), it offers versatile separation principles suitable for enriching acidic, neutral, and basic drugs from urine or plasma. Packaged in sets of 20 x 5 units, each column features an open tubular syringe-shaped design with a Luer tip outlet, filled with 100 mg of fully porous particles (FPP) of 45 µm size. Its pore size of 60 Å ensures efficient separation, while its specific surface area according to BET of 500 m²/g enhances adsorption capacity. The column's material, PP columns with PE filter elements, guarantees compatibility

• Category: SPE phases for pharmaceutical applications
• Separation principle: Special application or diverse
• Recommended application(s): E nrichment of acidic, neutral and basic drugs from urine or plasma.
• Column shape: Open tubular syringe-shaped column with Luer tip outlet
• Material text: Material: PP columns with PE filter elements.
• Similar phases: Strata™ Screen-C Bond Elut™ Certify I Discovery ® DSC-MCAX Clean Screen ® DAU AccuBond ® Evidex Bakerbond™ Narc-2 Isolute ® HCX LiChrolut ® TSC HyperSep™ Verify CX
• Particle type: Fully porous particles (FPP)
• Surface chemistry: Special bifunctional modification - C8/SA (octyl phase/strong cation exchanger – benzenesulfonic acid)
• Phase: Drug
• Packaging: 20 x 5 units
• Recommended storage temperature: RT
• Column type: SPE column
• Particle size: 45 µm
• Pore size: 60 Å
• pH stability: 2,0-8,0
• Specific surface according to BET: 500 m²/g
• Column volume: 1 ml
• Filling quantity: 100 mg